|
US FDA Unveils Its Strategic Plan to Improve Risk Communication
The U.S. Food and Drug Administration (FDA) will evaluate its framework for regulating promotions of devices and drugs to determine if new or revised legislation or regulations are needed as part of its new Strategic Plan for Risk Communication.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives